Low-grade dysplasia in an adenomatous polyp of the esophagus developing on pyloric-type heterotopic gastric mucosa treated with endoscopic mucosal resection: a case report

Esophagus ◽  
2005 ◽  
Vol 2 (4) ◽  
pp. 205-208 ◽  
Author(s):  
Tatsuhiko Hayashi ◽  
Kazuyasu Takizawa ◽  
Kazuaki Kobayashi ◽  
Naozumi Watanabe ◽  
Toshihiko Ikarashi
Keyword(s):  
Case Report ◽  
Gastric Mucosa ◽  
Endoscopic Mucosal Resection ◽  
Adenomatous Polyp ◽  
Heterotopic Gastric Mucosa ◽  
Low Grade ◽  
Mucosal Resection ◽  
Low Grade Dysplasia

Diagnostic Value of Endoscopic Mucosal Resection in Low Grade Dysplasia of Gastric Mucosa

2006 ◽  
Vol 63 (5) ◽  
pp. AB105
Author(s):  
Byoung Kuk Jang ◽  
Yeong Seok Lee ◽  
Seong Yeol Kim ◽  
Hong Sug Lee ◽  
Woo Jin Chung ◽  
...  
Keyword(s):  
Gastric Mucosa ◽  
Endoscopic Mucosal Resection ◽  
Diagnostic Value ◽  
Low Grade ◽  
Mucosal Resection ◽  
Low Grade Dysplasia

Endoscopic mucosal resection of adenocarcinoma arising in ectopic gastric mucosa in the cervical esophagus: case report

2003 ◽  
Vol 57 (2) ◽  
pp. 263-266 ◽  
Author(s):  
Nobuo Hirayama ◽  
Miwako Arima ◽  
Shin-ichi Miyazaki ◽  
Hideaki Shimada ◽  
Shin-ichi Okazumi ◽  
...  
Keyword(s):  
Case Report ◽  
Gastric Mucosa ◽  
Endoscopic Mucosal Resection ◽  
Cervical Esophagus ◽  
Ectopic Gastric Mucosa ◽  
Mucosal Resection

Endoscopic Therapy for Dysplastic Barrett Esophagus and Intramucosal Cancer

2018 ◽  
Author(s):  
Aymeric Becq ◽  
Tyler M Berzin
Keyword(s):  
Endoscopic Mucosal Resection ◽  
Endoscopic Therapy ◽  
Barrett Esophagus ◽  
Low Grade ◽  
High Grade ◽  
First Line ◽  
Mucosal Resection ◽  
First Line Therapy ◽  
Line Therapy ◽  
Low Grade Dysplasia

Barrett esophagus (BE) is a common premalignant condition that may evolve from nondysplastic intestinal metaplasia to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and ultimately to esophageal adenocarcinoma (EAC). This review addresses the range of endoscopic approaches for treating dysplastic BE and early EAC. Endoscopic treatment is favored for most patients with LGD, although endoscopic surveillance continues to be an alternative. Endoscopic eradication is definitively recommended for patients with HGD. Radiofrequency ablation is the preferred technique for ablation of dysplastic BE, although there is also strong support for endoscopic mucosal resection as a first-line therapy. Cryotherapy is emerging as a valid alternative ablative approach. Endoscopic resection by endoscopic mucosal resection or endoscopic submucosal dissection is recommended as the first-line therapy for nodular BE and T1a EAC. Post-eradication endoscopic surveillance is indicated at intervals that depend on the category of pretreatment dysplasia. Because of advances in endoscopic therapy, surgery is now indicated only when endoscopic ablation or resection has failed or in the setting of more advanced EAC. This review contains 8 figures, 2 tables, and 55 references. Key Words: cryotherapy, endoscopic mucosal resection, esophageal adenocarcinoma, esophagectomy, high-grade dysplasia, low-grade dysplasia, nodular Barrett esophagus, radiofrequency ablation

Early stage adenocarcinoma of the esophagus arising in circular heterotopic gastric mucosa treated by endoscopic mucosal resection

2001 ◽  
Vol 54 (5) ◽  
pp. 656-658 ◽  
Author(s):  
Oliver Pech ◽  
Andrea May ◽  
Liebwin Gossner ◽  
Michael Vieth ◽  
Friedrich Trump ◽  
...  
Keyword(s):  
Gastric Mucosa ◽  
Endoscopic Mucosal Resection ◽  
Early Stage ◽  
Heterotopic Gastric Mucosa ◽  
Adenocarcinoma Of The Esophagus ◽  
Mucosal Resection

Endoscopic Therapy for Dysplastic Barrett Esophagus and Intramucosal Cancer

2018 ◽  
Author(s):  
Aymeric Becq ◽  
Tyler M Berzin
Keyword(s):  
Endoscopic Mucosal Resection ◽  
Endoscopic Therapy ◽  
Barrett Esophagus ◽  
Low Grade ◽  
High Grade ◽  
First Line ◽  
Mucosal Resection ◽  
First Line Therapy ◽  
Line Therapy ◽  
Low Grade Dysplasia

Barrett esophagus (BE) is a common premalignant condition that may evolve from nondysplastic intestinal metaplasia to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and ultimately to esophageal adenocarcinoma (EAC). This review addresses the range of endoscopic approaches for treating dysplastic BE and early EAC. Endoscopic treatment is favored for most patients with LGD, although endoscopic surveillance continues to be an alternative. Endoscopic eradication is definitively recommended for patients with HGD. Radiofrequency ablation is the preferred technique for ablation of dysplastic BE, although there is also strong support for endoscopic mucosal resection as a first-line therapy. Cryotherapy is emerging as a valid alternative ablative approach. Endoscopic resection by endoscopic mucosal resection or endoscopic submucosal dissection is recommended as the first-line therapy for nodular BE and T1a EAC. Post-eradication endoscopic surveillance is indicated at intervals that depend on the category of pretreatment dysplasia. Because of advances in endoscopic therapy, surgery is now indicated only when endoscopic ablation or resection has failed or in the setting of more advanced EAC. This review contains 8 figures, 2 tables, and 55 references. Key Words: cryotherapy, endoscopic mucosal resection, esophageal adenocarcinoma, esophagectomy, high-grade dysplasia, low-grade dysplasia, nodular Barrett esophagus, radiofrequency ablation

Gastric Low-Grade Dysplasia: Follow-Up and Role of Endoscopic Mucosal Resection

2007 ◽  
Vol 65 (5) ◽  
pp. AB166
Author(s):  
Renzo Suriani ◽  
Valerio Marci ◽  
Dario Mazzucco ◽  
Ivo Venturini ◽  
Silvia Grosso ◽  
...  
Keyword(s):  
Endoscopic Mucosal Resection ◽  
Low Grade ◽  
Mucosal Resection ◽  
Low Grade Dysplasia
Sign in / Sign up

Export Citation Format

Share Document